Programs like One Great Community aim to engage communities in the process of population health research, which is a key to successful public health initiatives, explained Shauntice Allen, PhD, assistant professor in the University of Alabama at Birmingham School of Public Health.
Programs like One Great Community aim to engage communities in the process of population health research, which is a key to successful public health initiatives, explained Shauntice Allen, PhD, assistant professor in the University of Alabama at Birmingham School of Public Health.
Transcript (slightly modified)
What kind of work does the One Great Community program do?
One Great Community is the community engagement component of a larger grant initiative at UAB, University of Alabama at Birmingham, titled the CTSA, which is a part of the NIH enterprise. CTSA stands for Clinical and Translational Science Award, and there are 62 institutions across the country that have that funding, and UAB where I am is one of those places.
One Great Community’s real role and mission is to involve communities in how research is done, not just as study participants, but also as informers and influencers of what we study, what questions are asked, how those questions are answered, who’s at the table to help address that. That’s what One Great Community does.
What are some difficulties in applying public health research to real communities?
I think sometimes those of us who are in public health and who do public health research, sometimes it’s because there’s so many issues that one could address in a particular study, whatever it is. If you’re looking at diabetes in a population, or if you’re looking at the disease progression of cancer across the spectrum, if you’re doing bench science, for instance, I think sometimes the lines are blurred.
In public health we have a tendency, we want to do a lot of things when we may sometimes need to pull from the medical model and just focus on what it is that we really do know how to do, and address the issues that we are comfortable working in. Public health is such a big field, and everything is public health, particularly when it comes to training young professionals and those who are going to go out into the field, be your boots on the ground, be a researcher, be running a health department or whatever.
Number one, understanding what public health is, it’s a lot of things. But at the end of the day what we’re trying to do is just impact health, communities’ health.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Advancing Women's Health: CVS Health Leader on Access, Technology, and Breaking Stigmas
December 5th 2024On this episode of Managed Care Cast, we speak with CVS Health's vice president and chief medical officer for women's health and genomics about advancements and challenges in women's health, focusing on care access, technology, and maternal outcomes.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Healing Wounds Through Peer Support
September 16th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this third episode, we speak with Kim MacDonald-Wilson, ScD, CPRP, and Tracy Carney, CPS, CPRP.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More